PortalPublikationenIndication and short-term clinical outcomes of high-risk per...

Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry

Standard

Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry. / Baumann, Stefan; Werner, Nikos; Ibrahim, Karim; Westenfeld, Ralf; Al-Rashid, Fadi; Sinning, Jan-Malte; Westermann, Dirk; Schäfer, Andreas; Karatolios, Konstantinos; Bauer, Timm; Becher, Tobias; Akin, Ibrahim.

in: CLIN RES CARDIOL, Jahrgang 107, Nr. 8, 08.2018, S. 653-657.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Baumann, S, Werner, N, Ibrahim, K, Westenfeld, R, Al-Rashid, F, Sinning, J-M, Westermann, D, Schäfer, A, Karatolios, K, Bauer, T, Becher, T & Akin, I 2018, 'Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry', CLIN RES CARDIOL, Jg. 107, Nr. 8, S. 653-657. https://doi.org/10.1007/s00392-018-1230-6

APA

Baumann, S., Werner, N., Ibrahim, K., Westenfeld, R., Al-Rashid, F., Sinning, J-M., Westermann, D., Schäfer, A., Karatolios, K., Bauer, T., Becher, T., & Akin, I. (2018). Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry. CLIN RES CARDIOL, 107(8), 653-657. https://doi.org/10.1007/s00392-018-1230-6

Vancouver

Baumann S, Werner N, Ibrahim K, Westenfeld R, Al-Rashid F, Sinning J-M et al. Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry. CLIN RES CARDIOL. 2018 Aug;107(8):653-657. https://doi.org/10.1007/s00392-018-1230-6

Bibtex

@article{dd28fcff4f5e420e8ae2ad499f2a4e5c,
title = "Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella{\textregistered} pump: results from the German Impella{\textregistered} registry",
abstract = "BACKGROUND: Percutaneous coronary intervention (PCI) is an alternative strategy to coronary artery bypass grafting (CABG) in patients with high perioperative risk. The microaxial Impella{\textregistered} pump (Abiomed, Danvers, MA, USA), used as prophylactic and temporary support, is currently the most common device for {"}protected high-risk PCI{"} to ensure hemodynamic stability during complex coronary intervention.METHODS: The study is an observational, retrospective multi-center registry. Patients from nine tertiary hospitals in Germany, who have undergone protected high-risk PCI, are included in the present study.RESULTS: A total of 154 patients (mean age 72.6-10.8 years, 75.3% male) were enrolled. The majority were at a high operative risk illustrated by a logistic EuroSCORE of 14.7-17.4. The initial SYNTAX score was 32.0-13.3, indicating very complex CAD and could be reduced to 14.1-14.3 (p < 0.0001) after PCI. The main reasons for protected PCI were complex coronary anatomy (70.8%), personal impression (56.5%), reduced ventricular ejection fraction (49.4%), comorbidities (47.4%), and surgical turndown (30.5%). Four patients (2.6%) experienced an intrahospital death.CONCLUSIONS: Data from the study show that protected PCI is a safe and effective approach to revascularize high-risk patients with complex coronary anatomy and comorbidities.",
keywords = "Aged, Coronary Artery Disease/physiopathology, Female, Germany, Heart-Assist Devices, Humans, Male, Percutaneous Coronary Intervention/methods, Prosthesis Design, Registries, Retrospective Studies, Ventricular Function, Left/physiology",
author = "Stefan Baumann and Nikos Werner and Karim Ibrahim and Ralf Westenfeld and Fadi Al-Rashid and Jan-Malte Sinning and Dirk Westermann and Andreas Sch{\"a}fer and Konstantinos Karatolios and Timm Bauer and Tobias Becher and Ibrahim Akin",
year = "2018",
month = aug,
doi = "10.1007/s00392-018-1230-6",
language = "English",
volume = "107",
pages = "653--657",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "8",

}

RIS

TY - JOUR

T1 - Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry

AU - Baumann, Stefan

AU - Werner, Nikos

AU - Ibrahim, Karim

AU - Westenfeld, Ralf

AU - Al-Rashid, Fadi

AU - Sinning, Jan-Malte

AU - Westermann, Dirk

AU - Schäfer, Andreas

AU - Karatolios, Konstantinos

AU - Bauer, Timm

AU - Becher, Tobias

AU - Akin, Ibrahim

PY - 2018/8

Y1 - 2018/8

N2 - BACKGROUND: Percutaneous coronary intervention (PCI) is an alternative strategy to coronary artery bypass grafting (CABG) in patients with high perioperative risk. The microaxial Impella® pump (Abiomed, Danvers, MA, USA), used as prophylactic and temporary support, is currently the most common device for "protected high-risk PCI" to ensure hemodynamic stability during complex coronary intervention.METHODS: The study is an observational, retrospective multi-center registry. Patients from nine tertiary hospitals in Germany, who have undergone protected high-risk PCI, are included in the present study.RESULTS: A total of 154 patients (mean age 72.6-10.8 years, 75.3% male) were enrolled. The majority were at a high operative risk illustrated by a logistic EuroSCORE of 14.7-17.4. The initial SYNTAX score was 32.0-13.3, indicating very complex CAD and could be reduced to 14.1-14.3 (p < 0.0001) after PCI. The main reasons for protected PCI were complex coronary anatomy (70.8%), personal impression (56.5%), reduced ventricular ejection fraction (49.4%), comorbidities (47.4%), and surgical turndown (30.5%). Four patients (2.6%) experienced an intrahospital death.CONCLUSIONS: Data from the study show that protected PCI is a safe and effective approach to revascularize high-risk patients with complex coronary anatomy and comorbidities.

AB - BACKGROUND: Percutaneous coronary intervention (PCI) is an alternative strategy to coronary artery bypass grafting (CABG) in patients with high perioperative risk. The microaxial Impella® pump (Abiomed, Danvers, MA, USA), used as prophylactic and temporary support, is currently the most common device for "protected high-risk PCI" to ensure hemodynamic stability during complex coronary intervention.METHODS: The study is an observational, retrospective multi-center registry. Patients from nine tertiary hospitals in Germany, who have undergone protected high-risk PCI, are included in the present study.RESULTS: A total of 154 patients (mean age 72.6-10.8 years, 75.3% male) were enrolled. The majority were at a high operative risk illustrated by a logistic EuroSCORE of 14.7-17.4. The initial SYNTAX score was 32.0-13.3, indicating very complex CAD and could be reduced to 14.1-14.3 (p < 0.0001) after PCI. The main reasons for protected PCI were complex coronary anatomy (70.8%), personal impression (56.5%), reduced ventricular ejection fraction (49.4%), comorbidities (47.4%), and surgical turndown (30.5%). Four patients (2.6%) experienced an intrahospital death.CONCLUSIONS: Data from the study show that protected PCI is a safe and effective approach to revascularize high-risk patients with complex coronary anatomy and comorbidities.

KW - Aged

KW - Coronary Artery Disease/physiopathology

KW - Female

KW - Germany

KW - Heart-Assist Devices

KW - Humans

KW - Male

KW - Percutaneous Coronary Intervention/methods

KW - Prosthesis Design

KW - Registries

KW - Retrospective Studies

KW - Ventricular Function, Left/physiology

U2 - 10.1007/s00392-018-1230-6

DO - 10.1007/s00392-018-1230-6

M3 - SCORING: Journal article

C2 - 29520699

VL - 107

SP - 653

EP - 657

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

IS - 8

ER -